Exclusive Strategies on Parkinson’s Disease Treatment Market Studied in Detail by Focusing on Top Companies- Teva Pharmaceuticals Inc., Novartis AG, GlaxoSmithKline Inc., AbbVie Inc., Merck & Company
Parkinson’s disease (PD) is a neurodegenerative disorder, that is caused due to the loss of dopamine production in the brain. It leads to progressive deterioration of motor function in the human body affecting the brain, and nerve cells. It can be recognized with the barely noticeable tremor in one hand, but is one of the most significant symptoms that can help the doctors in recognizing Parkinson’s disease at an early stage. Parkinson’s disease is noticeably caused due to various environmental factors, and genetic mutations. In addition, it causes problems such as thinking difficulties, depression, and emotional change, swallowing problems, sleep disorder, constipation, and bladder problems.
Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s. The number of people globally suffering from Parkinson’s disease is around 10 million, or it ranges around 41 people per 1,00,000. Men are likely to get affected 1.5 times higher than a woman.
Request Sample Pages for more Professional and Technical insights @
Parkinson’s disease, can be recognized initially through decreased movement of arms while walking, stiffness, slowness in performing any task. Moreover, some secondary symptoms include anxiety, depression, and dementia. This disease is found in the individuals with age range of around 60 years, and impairment of the disease varies from person to person. The study shows that the time that primary symptoms are observed about 60 to 80% of dopamine-producing cells are damaged in the brain. This damage to the brain cell is caused due to neurons break down, leading to loss of brain activity, and some signs of Parkinson’s disease.
Parkinson’s Disease Treatment Market to notice positive growth owing to its rising prevalence, and increasing awareness about the diagnosis of Parkinson’s disease at an initial stage.
Growth Analysis: -
Parkinson’s Disease Treatment Market is primarily driven by rising prevalence of Parkinson’s disease, due to increased life expectancy across the globe. For instance, the data presented by WHO in 2015, stated the average ‘life expectancy of a person was 70 years and would continue to increase. Additionally, a continuous surge in the investment by the leading players for discovering various treatment options for PD. Geographically, Japan has the highest life expectancy which makes it an effective location. Thus, the leading companies focus has now shifted toward the developing countries.
Key players in the Parkinson’s Disease Treatment Market are:
• Teva Pharmaceuticals Inc.
• Novartis AG
• GlaxoSmithKline Inc.
• AbbVie Inc.
• Merck & Company
• Boehringer Ingelheium Inc.
• Impax Laboratories
• Sun Pharma
• Valeant Pharmaceuticals
• UCB Inc.
For 'Queries' related to this research report, Make an Enquiry @
Regional Outlook: -
Europe region is expected to dominate the Parkinson’s Disease Treatment Market over the forecast period. Europe holds major share owning to the continuous technological developments by the increasing R&D investments.
While, North America is considered to hold the second largest market share among regions, but Asia Pacific is expected to grow rapidly during the forecast period. Growing patient count along with support from governments in terms of expenditure for developing healthcare infrastructure are the major factors that anticipate to govern the growth of Parkinson’s Disease Treatment in Asia Pacific region during upcoming years.
Table of Content of Parkinson’s Disease Treatment Market:
Chapter 1. Overview and Scope
Chapter 2. Market Summary
Chapter 3 Parkinson’s Disease Treatment Market Size and Forecast
Chapter 4. Dynamics and Segmentation
Chapter 5. Detailed Insight on Key Company
Chapter 6. Research Methodology and Reference
Chapter 7. Competitive Landscape
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
Corporate Sales, USA
Polaris Market Research and Consulting
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exclusive Strategies on Parkinson’s Disease Treatment Market Studied in Detail by Focusing on Top Companies- Teva Pharmaceuticals Inc., Novartis AG, GlaxoSmithKline Inc., AbbVie Inc., Merck & Company here
News-ID: 1350153 • Views: 1936
More Releases from Polaris Market Research & Consulting
What's driving the Blockchain Technology Market Trends? Microsoft Corporation, I …
The worldwide market size for blockchain technology is estimated to grow at a CAGR of 41.6% between 2018 and 2026 and is anticipated to reach USD 16.82 billion by 2026. According to a new study published by Polaris Market Research. Also termed as Distributed Ledger Technology (DLT), blockchain enables secure transaction over a distributed network. Since the transactions are taken place usually over the network, it is difficult to reverse
What's driving the Precision Farming Market Trends? Ag Leader Technology, AgJunc …
The global precision farming/agriculture market was valued at 3,833 million in 2017 and is anticipated to reach over USD 13,016 million by 2026 with grow at a CAGR of more than 14.7% during the forecast period According to a new study published by Polaris Market Research. In 2017, the yield monitoring application dominated the global market, in terms of revenue. North America is expected to be the leading contributor to
What are the different trends in Electric Vehicles (EV) Market to boost its grow …
Polaris Market Research has new report published the addition of the “The global Electric Vehicles Market Worth $912 Billion By 2026 | CAGR: 38.4%”, the report classifies the global Electric Vehicles market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth Get PDF Sample of “Electric Vehicles Market”: https://www.polarismarketresearch.com/industry-analysis/electric-vehicles-ev-market/request-for-sample The global electric vehicles market is anticipated to
What are the different trends in Third Party Logistics Market to boost its growt …
Polaris Market Research has new report published the addition of the “The global third-party logistics market is anticipated to reach USD 1,337.91 billion by 2026”, the report classifies the global third-party logistics market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth according to a new report The report “Third Party Logistics (3PL) Market Share, Size,
More Releases for Parkinson’s
Parkinson’s Disease Therapeutic Market- Trends, Outlook 2025
Parkinson’s disease (PD) is a chronic disorder characterized by the malfunctioning and death of vital nerve cells in the brain, and can be characterized by tremor, dementia, and depression. Parkinson’s disease progression leads to uncontrolled body movement of the patient. There is no cure presently for parkinson’s disease only treatments options such as medication and surgery to manage the symptoms are available. Parkinson’s disease mainly affects people over 50 and
Parkinson’s disease Therapeutics Parkinson’s disease Therapeutics Market to …
This report studies the global Parkinson's Disease Therapeutics market, analyzes and researches the Parkinson's Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie ….. Ask for sample copy @ https://www.researchtrades.com/request-sample/1199125 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Parkinson's Disease Therapeutics can be split into Medications Therapeutics Medical Devices Therapeutics Buy
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent. Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial